Showing results (11-20 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|January 12, 2011
Genome-wide association study of serious blistering skin rash caused by drugsY Shen, P Nicoletti, A Floratos, et al.
The Pharmacogenomics Journal|December 22, 2010
Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among BraziliansG Suarez-Kurtz, J P Genro, M O de Moraes, et al.
The Pharmacogenomics Journal|December 22, 2010
Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypesS Mas, P Gassò, S Alvarez, et al.
The Pharmacogenomics Journal|December 22, 2010
Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophreniaW Liu, A C M Downing, L M Munsie, et al.
The Pharmacogenomics Journal|December 15, 2010
High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcomeR A Wilke
The Pharmacogenomics Journal|March 2, 2011
SNP discovery, expression and cis-regulatory variation in the UGT2B genesC Sun, C Southard, D Huo, et al.
The Pharmacogenomics Journal|March 2, 2011
Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsivenessS A Scott, S Martis, I Peter, et al.
The Pharmacogenomics Journal|April 20, 2011
Economic impact of a genetic test for cisplatin-induced ototoxicityF Dionne, C Mitton, R Rassekh, et al.
The Pharmacogenomics Journal|March 2, 2021
Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipientsDina Chen, Huijie Lu, Weiguo Sui, et al.
The Pharmacogenomics Journal|March 2, 2021
Transcriptional analysis of sodium valproate in a serotonergic cell line reveals gene regulation through both HDAC inhibition-dependent and independent mechanismsPriyanka Sinha, Simone L Cree, Allison L Miller, et al.
Pageof 135